The Latest
FDA Approves Nayzilam Nasal Spray to Treat Seizure Clusters
Inclisiran Associated With Sustained LDL-C Reduction in ORION-3 Study
Obesity Does Not Increase ICU Mortality Rate in Acute Respiratory Failure
PONENTE Trial May Provide Guidance for OCS Tapering in Asthma
Aclidinium Delays COPD Event Onset, Does Not Increase MACE Risk
NDA for Twirla Contraceptive Patch Resubmitted to FDA
Factors Affecting Lung Function Improvement With Omalizumab
Pulmonary Vasodilators Reduce Mortality in Pediatric Pulmonary Hypertension
Mepolizumab and High-Baseline EDN Linked to Lower Asthma Exacerbation Rates
MPR ARTICLES
